Cascadian Therapeutics, Inc. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cascadian Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cascadian Therapeutics, Inc. for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2014 | ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Option Exercise | M | 0.00 | 19,352 | 0 | 0 | |
Mar 12 2014 | ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Payment of Exercise | F | 3.65 | 4,838 | 17,659 | 48,736 | 53.6 K to 48.7 K (-9.03 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Buy | M | 0.00 | 19,352 | 0 | 53,574 | 34.2 K to 53.6 K (+56.55 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Option Exercise | M | 0.00 | 19,352 | 0 | 0 | |
Mar 12 2014 | ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Payment of Exercise | F | 3.65 | 4,838 | 17,659 | 38,871 | 43.7 K to 38.9 K (-11.07 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Buy | M | 0.00 | 19,352 | 0 | 43,709 | 24.4 K to 43.7 K (+79.45 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Option Exercise | M | 0.00 | 19,352 | 0 | 0 | |
Mar 12 2014 | ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Payment of Exercise | F | 3.65 | 4,838 | 17,659 | 49,570 | 54.4 K to 49.6 K (-8.89 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Buy | M | 0.00 | 19,352 | 0 | 54,408 | 35.1 K to 54.4 K (+55.20 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 19,352 | 0 | 0 | |
Mar 12 2014 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.65 | 4,838 | 17,659 | 125,820 | 130.7 K to 125.8 K (-3.70 %) |
Mar 12 2014 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 19,352 | 0 | 130,658 | 111.3 K to 130.7 K (+17.39 %) |